Call +44 (0)1904 798634 or +44 (0)7550 079918

Leading provider of life science market reports and research services

Alzheimer Diagnostic Tests - Medical Devices Pipeline Assessment, 2015

Be the first to review this product

Alzheimer Diagnostic Tests - Medical Devices Pipeline Assessment, 2015

Summary

GlobalData's Medical Devices sector report, 'Alzheimer Diagnostic Tests - Medical Devices Pipeline Assessment, 2015'...
You can choose to pay by purchase order during checkout

Availability: In stock

$4,000.00

* Required Fields

You can choose to pay by purchase order during checkout
GlobalData.

Digital downloads direct to your inbox within 24 hours.

First class customer service from our team of experts.

Pay by credit card or request an invoice

Product Description

Details

Alzheimer Diagnostic Tests - Medical Devices Pipeline Assessment, 2015

Summary

GlobalData's Medical Devices sector report, 'Alzheimer Diagnostic Tests - Medical Devices Pipeline Assessment, 2015' provides an overview of Alzheimer Diagnostic Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Alzheimer Diagnostic Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Alzheimer Diagnostic Tests under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Alzheimer Diagnostic Tests and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Alzheimer Diagnostic Tests under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date

Additional Information

Additional Information

Publisher name GlobalData.
Format PDF
Page count 216
Publication date 5 Jan 2016
Table of contents 1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 8
1.2 List of Figures 17
2 Introduction 18
2.1 Alzheimer Diagnostic Tests Overview 18
3 Products under Development 19
3.1 Alzheimer - Pipeline Products by Stage of Development 19
3.2 Alzheimer - Pipeline Products by Territory 20
3.3 Alzheimer - Pipeline Products by Regulatory Path 21
3.4 Alzheimer - Pipeline Products by Estimated Approval Date 22
3.5 Alzheimer - Ongoing Clinical Trials 23
4 Alzheimer - Pipeline Products under Development by Companies 24
4.1 Alzheimer Companies - Pipeline Products by Stage of Development 24
4.2 Alzheimer - Pipeline Products by Stage of Development 29
5 Alzheimer Companies and Product Overview 34
5.1 AC Immune SA Company Overview 34
5.1.1 AC Immune SA Pipeline Products & Ongoing Clinical Trials Overview 34
5.2 Acobiom Company Overview 37
5.2.1 Acobiom Pipeline Products & Ongoing Clinical Trials Overview 37
5.3 Acumen Pharmaceuticals, Inc. Company Overview 40
5.3.1 Acumen Pharmaceuticals, Inc. Pipeline Products & Ongoing Clinical Trials Overview 40
5.4 Adlyfe Inc. Company Overview 42
5.4.1 Adlyfe Inc. Pipeline Products & Ongoing Clinical Trials Overview 42
5.5 Advanced Genomic Technology, LLC Company Overview 43
5.5.1 Advanced Genomic Technology, LLC Pipeline Products & Ongoing Clinical Trials Overview 43
5.6 ADx NeuroSciences NV Company Overview 44
5.6.1 ADx NeuroSciences NV Pipeline Products & Ongoing Clinical Trials Overview 44
5.7 Akrivis Technologies, LLC Company Overview 58
5.7.1 Akrivis Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 58
5.8 Alere Inc. Company Overview 59
5.8.1 Alere Inc. Pipeline Products & Ongoing Clinical Trials Overview 59
5.9 Alzhyme Pty Ltd Company Overview 61
5.9.1 Alzhyme Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 61
5.10 Amarantus Bioscience Holdings, Inc. Company Overview 62
5.10.1 Amarantus Bioscience Holdings, Inc. Pipeline Products & Ongoing Clinical Trials Overview 62
5.11 Applied Proteomics, Inc. Company Overview 66
5.11.1 Applied Proteomics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 66
5.12 Araclon Biotech, S.L. Company Overview 67
5.12.1 Araclon Biotech, S.L. Pipeline Products & Ongoing Clinical Trials Overview 67
5.13 Banyan Biomarkers, Inc. Company Overview 68
5.13.1 Banyan Biomarkers, Inc. Pipeline Products & Ongoing Clinical Trials Overview 68
5.14 BioArctic Neuroscience AB Company Overview 69
5.14.1 BioArctic Neuroscience AB Pipeline Products & Ongoing Clinical Trials Overview 69
5.15 biOasis Technologies Inc. Company Overview 70
5.15.1 biOasis Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 70
5.16 Biomedical Development Corporation Company Overview 71
5.16.1 Biomedical Development Corporation Pipeline Products & Ongoing Clinical Trials Overview 71
5.17 BioSystems International Company Overview 72
5.17.1 BioSystems International Pipeline Products & Ongoing Clinical Trials Overview 72
5.18 C2N Diagnostics LLC Company Overview 73
5.18.1 C2N Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 73
5.19 Chronix Biomedical, Inc. Company Overview 74
5.19.1 Chronix Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 74
5.20 Cognoptix, Inc. Company Overview 76
5.20.1 Cognoptix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 76
5.21 Columbia University Company Overview 80
5.21.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview 80
5.22 CompanDX Ltd. Company Overview 83
5.22.1 CompanDX Ltd. Pipeline Products & Ongoing Clinical Trials Overview 83
5.23 Consejo Superior de Investigaciones Cientificas Company Overview 84
5.23.1 Consejo Superior de Investigaciones Cientificas Pipeline Products & Ongoing Clinical Trials Overview 84
5.24 Cymedx Company Overview 86
5.24.1 Cymedx Pipeline Products & Ongoing Clinical Trials Overview 86
5.25 DiaGenic ASA Company Overview 87
5.25.1 DiaGenic ASA Pipeline Products & Ongoing Clinical Trials Overview 87
5.26 DiamiR LLC Company Overview 94
5.26.1 DiamiR LLC Pipeline Products & Ongoing Clinical Trials Overview 94
5.27 DiaPat GmbH Company Overview 95
5.27.1 DiaPat GmbH Pipeline Products & Ongoing Clinical Trials Overview 95
5.28 Diaxonhit S.A. Company Overview 96
5.28.1 Diaxonhit S.A. Pipeline Products & Ongoing Clinical Trials Overview 96
5.29 Dr. Grossegger & Drbal GmbH Company Overview 97
5.29.1 Dr. Grossegger & Drbal GmbH Pipeline Products & Ongoing Clinical Trials Overview 97
5.30 DS Pharma Biomedical Co., Ltd. Company Overview 98
5.30.1 DS Pharma Biomedical Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 98
5.31 Durin Technologies, Inc. Company Overview 99
5.31.1 Durin Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 99
5.32 Emory University Company Overview 100
5.32.1 Emory University Pipeline Products & Ongoing Clinical Trials Overview 100
5.33 Fianostics GmbH Company Overview 101
5.33.1 Fianostics GmbH Pipeline Products & Ongoing Clinical Trials Overview 101
5.34 Gene Solutions LLC Company Overview 102
5.34.1 Gene Solutions LLC Pipeline Products & Ongoing Clinical Trials Overview 102
5.35 GeneNews Limited Company Overview 103
5.35.1 GeneNews Limited Pipeline Products & Ongoing Clinical Trials Overview 103
5.36 Genentech, Inc. Company Overview 105
5.36.1 Genentech, Inc. Pipeline Products & Ongoing Clinical Trials Overview 105
5.37 Georg-August-Universitat Gottingen Company Overview 107
5.37.1 Georg-August-Universitat Gottingen Pipeline Products & Ongoing Clinical Trials Overview 107
5.38 Ghent University Company Overview 110
5.38.1 Ghent University Pipeline Products & Ongoing Clinical Trials Overview 110
5.39 HealthTell, Inc. Company Overview 111
5.39.1 HealthTell, Inc. Pipeline Products & Ongoing Clinical Trials Overview 111
5.40 ICDD-sas Company Overview 112
5.40.1 ICDD-sas Pipeline Products & Ongoing Clinical Trials Overview 112
5.41 Innovative California Biosciences International, Inc. Company Overview 115
5.41.1 Innovative California Biosciences International, Inc. Pipeline Products & Ongoing Clinical Trials Overview 115
5.42 Innovative Health Diagnostics Company Overview 122
5.42.1 Innovative Health Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 122
5.43 Institut National de la Sante et de la Recherche Medicale Company Overview 123
5.43.1 Institut National de la Sante et de la Recherche Medicale Pipeline Products & Ongoing Clinical Trials Overview 123
5.44 Instituto de Estructura de la Materia Company Overview 124
5.44.1 Instituto de Estructura de la Materia Pipeline Products & Ongoing Clinical Trials Overview 124
5.45 Integrated Diagnostics Inc. Company Overview 125
5.45.1 Integrated Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview 125
5.46 Janssen Pharmaceutica N.V. Company Overview 126
5.46.1 Janssen Pharmaceutica N.V. Pipeline Products & Ongoing Clinical Trials Overview 126
5.47 KineMed, Inc. Company Overview 127
5.47.1 KineMed, Inc. Pipeline Products & Ongoing Clinical Trials Overview 127
5.48 Laboratory Corporation of America Holdings Company Overview 128
5.48.1 Laboratory Corporation of America Holdings Pipeline Products & Ongoing Clinical Trials Overview 128
5.49 McGill University Health Center Company Overview 130
5.49.1 McGill University Health Center Pipeline Products & Ongoing Clinical Trials Overview 130
5.50 Memory Dx, LLC Company Overview 131
5.50.1 Memory Dx, LLC Pipeline Products & Ongoing Clinical Trials Overview 131
5.51 Meso Scale Diagnostics LLC Company Overview 132
5.51.1 Meso Scale Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 132
5.52 Myriad Genetics, Inc. Company Overview 133
5.52.1 Myriad Genetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 133
5.53 NanoSomiX, Inc. Company Overview 135
5.53.1 NanoSomiX, Inc. Pipeline Products & Ongoing Clinical Trials Overview 135
5.54 Nanosphere, Inc. Company Overview 137
5.54.1 Nanosphere, Inc. Pipeline Products & Ongoing Clinical Trials Overview 137
5.55 Neuron Biopharma SA Company Overview 139
5.55.1 Neuron Biopharma SA Pipeline Products & Ongoing Clinical Trials Overview 139
5.56 NeuroQuest, Ltd. Company Overview 141
5.56.1 NeuroQuest, Ltd. Pipeline Products & Ongoing Clinical Trials Overview 141
5.57 Neurotrope Bioscience, Inc. Company Overview 142
5.57.1 Neurotrope Bioscience, Inc. Pipeline Products & Ongoing Clinical Trials Overview 142
5.58 NeuroVision Imaging LLC. Company Overview 143
5.58.1 NeuroVision Imaging LLC. Pipeline Products & Ongoing Clinical Trials Overview 143
5.59 Newcastle University Company Overview 144
5.59.1 Newcastle University Pipeline Products & Ongoing Clinical Trials Overview 144
5.60 NextGen Sciences Dx Inc Company Overview 146
5.60.1 NextGen Sciences Dx Inc Pipeline Products & Ongoing Clinical Trials Overview 146
5.61 Novel Bio-spectrum Technologies, Inc. Company Overview 147
5.61.1 Novel Bio-spectrum Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 147
5.62 Oligomerix, inc. Company Overview 148
5.62.1 Oligomerix, inc. Pipeline Products & Ongoing Clinical Trials Overview 148
5.63 OPKO Health, Inc. Company Overview 149
5.63.1 OPKO Health, Inc. Pipeline Products & Ongoing Clinical Trials Overview 149
5.64 Orasi Medical, Inc. Company Overview 152
5.64.1 Orasi Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 152
5.65 Oregon Health & Science University Company Overview 156
5.65.1 Oregon Health & Science University Pipeline Products & Ongoing Clinical Trials Overview 156
5.66 Oryzon Genomics S.A. Company Overview 157
5.66.1 Oryzon Genomics S.A. Pipeline Products & Ongoing Clinical Trials Overview 157
5.67 Oxford Biodynamics Limited Company Overview 159
5.67.1 Oxford Biodynamics Limited Pipeline Products & Ongoing Clinical Trials Overview 159
5.68 PDx BioTech Company Overview 161
5.68.1 PDx BioTech Pipeline Products & Ongoing Clinical Trials Overview 161
5.69 PeriRx LLC Company Overview 162
5.69.1 PeriRx LLC Pipeline Products & Ongoing Clinical Trials Overview 162
5.70 Pre Diagnostics AS Company Overview 163
5.70.1 Pre Diagnostics AS Pipeline Products & Ongoing Clinical Trials Overview 163
5.71 Predemtec GmbH Company Overview 164
5.71.1 Predemtec GmbH Pipeline Products & Ongoing Clinical Trials Overview 164
5.72 ProMIS Neurosciences Inc. Company Overview 165
5.72.1 ProMIS Neurosciences Inc. Pipeline Products & Ongoing Clinical Trials Overview 165
5.73 Proplex Technologies, Llc Company Overview 167
5.73.1 Proplex Technologies, Llc Pipeline Products & Ongoing Clinical Trials Overview 167
5.74 Protagen AG Company Overview 169
5.74.1 Protagen AG Pipeline Products & Ongoing Clinical Trials Overview 169
5.75 Proteome Sciences Plc Company Overview 170
5.75.1 Proteome Sciences Plc Pipeline Products & Ongoing Clinical Trials Overview 170
5.76 Proteomics International Pty Ltd Company Overview 173
5.76.1 Proteomics International Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 173
5.77 Quanterix Corporation Company Overview 174
5.77.1 Quanterix Corporation Pipeline Products & Ongoing Clinical Trials Overview 174
5.78 Redox Diagnostics LLC Company Overview 175
5.78.1 Redox Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 175
5.79 Saladax Biomedical, Inc. Company Overview 176
5.79.1 Saladax Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 176
5.80 Satoris, Inc. Company Overview 177
5.80.1 Satoris, Inc. Pipeline Products & Ongoing Clinical Trials Overview 177
5.81 Scout Diagnostics, LLC Company Overview 178
5.81.1 Scout Diagnostics, LLC Pipeline Products & Ongoing Clinical Trials Overview 178
5.82 Singulex, Inc. Company Overview 179
5.82.1 Singulex, Inc. Pipeline Products & Ongoing Clinical Trials Overview 179
5.83 SomaLogic, Inc. Company Overview 180
5.83.1 SomaLogic, Inc. Pipeline Products & Ongoing Clinical Trials Overview 180
5.84 Takeda Pharmaceuticals International AG Company Overview 181
5.84.1 Takeda Pharmaceuticals International AG Pipeline Products & Ongoing Clinical Trials Overview 181
5.85 The Johns Hopkins University Company Overview 183
5.85.1 The Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 183
5.86 The University of Melbourne Company Overview 184
5.86.1 The University of Melbourne Pipeline Products & Ongoing Clinical Trials Overview 184
5.87 Trinity College Dublin Company Overview 185
5.87.1 Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview 185
5.88 True Diagnostics, Inc. Company Overview 186
5.88.1 True Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 186
5.89 University of California, Irvine Company Overview 187
5.89.1 University of California, Irvine Pipeline Products & Ongoing Clinical Trials Overview 187
5.90 University of Chicago Company Overview 188
5.90.1 University of Chicago Pipeline Products & Ongoing Clinical Trials Overview 188
5.91 University of Georgia Company Overview 189
5.91.1 University of Georgia Pipeline Products & Ongoing Clinical Trials Overview 189
5.92 University of Luxembourg Company Overview 190
5.92.1 University of Luxembourg Pipeline Products & Ongoing Clinical Trials Overview 190
5.93 University of Nottingham Company Overview 191
5.93.1 University of Nottingham Pipeline Products & Ongoing Clinical Trials Overview 191
5.94 University of South Florida Company Overview 192
5.94.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 192
5.95 University of Texas Health Science Center at Houston Company Overview 193
5.95.1 University of Texas Health Science Center at Houston Pipeline Products & Ongoing Clinical Trials Overview 193
5.96 University of Texas Southwestern Medical Center at Dallas Company Overview 195
5.96.1 University of Texas Southwestern Medical Center at Dallas Pipeline Products & Ongoing Clinical Trials Overview 195
5.97 US Biomarkers, Inc. Company Overview 197
5.97.1 US Biomarkers, Inc. Pipeline Products & Ongoing Clinical Trials Overview 197
5.98 Vermillion, Inc. Company Overview 198
5.98.1 Vermillion, Inc. Pipeline Products & Ongoing Clinical Trials Overview 198
5.99 Vitruvian Biomedical, Inc. Company Overview 200
5.99.1 Vitruvian Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 200
5.100 Washington University in St. Louis Company Overview 201
5.100.1 Washington University in St. Louis Pipeline Products & Ongoing Clinical Trials Overview 201
5.101 XRGenomics LTD Company Overview 205
5.101.1 XRGenomics LTD Pipeline Products & Ongoing Clinical Trials Overview 205
5.102 Zoiray Technologies Inc. Company Overview 206
5.102.1 Zoiray Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 206
6 Alzheimer- Recent Developments 207
7 Appendix 213
7.1 Methodology 213
7.2 About GlobalData 215
7.3 Contact Us 216
7.4 Disclaimer 216

Reviews

Write Your Own Review

Only registered users can write reviews. Please, log in or register

Product Tags

Product Tags

Use spaces to separate tags. Use single quotes (') for phrases.